Bird Flu Market Growth Driven by Rising Demand for Animal Protein and Enhanced Biosecurity Measures

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bird Flu Market - (By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, Others), By Animal Type (Chickens, Ducks, Geese & Swans, Pigeons, Guinea Fowls, Turkeys, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Bird Flu Market is valued at US$ 1.41 Bn in 2023, and it is expected to reach US$ 2.17 Bn by 2031, with a CAGR of 5.82% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2347

Avian influenza, commonly referred to as bird flu, primarily impacts avian species but has demonstrated the potential to infect humans and other animals. While it shares certain characteristics with seasonal human influenza viruses, bird flu is generally more virulent within bird populations. Growth in the global bird flu market is expected to be driven by increased governmental investment in the development of effective treatments, as well as rising mortality rates among birds due to viral infections.

Key market dynamics are influenced by the emergence of new viral strains, changes in poultry farming practices, international trade activities, and advancements in healthcare technologies. Although human cases of infection remain infrequent, the risk of widespread outbreaks and the associated disruptions to the poultry industry highlight the critical need for ongoing public health preparedness and economic risk management.

List of Prominent Players in the Bird Flu Market
• Boehringer Ingelheim
• Ceva Santé Animale
• Zoetis
• Merck & Co.
• Ringpu Biology
• Yebio Bioengineering
• FATRO
• CAVAC
• ChengDu Tecbond
• QYH Biotech
• Elanco
• Phibro Animal Health
• Vetoquinol
• Hipra
• Venkys
• Anicon Labor GmbH
• Bioveta
• Lohmann Animal Health
• Biogenesis Bago
• Sanofi
• F. Hoffmann-La Roche Ltd.
• Mallinckrodt
• GlaxoSmithKline plc
• Novartis AG
• Bayer AG
• Eli Lilly and Company
• AstraZeneca
• Johnson & Johnson Private Limited
• Bimeda, Inc.
• Phibro Animal Health Corporation
• Medion
• Other prominent players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The global demand for animal protein, particularly pork, poultry, and other meat products, has increased significantly in recent decades, largely driven by rapid population growth. This expansion in livestock populations has heightened the vulnerability of certain species-most notably chickens and ducks-to viral infections such as avian influenza.

Migratory wild birds, including ducks, geese, and shorebirds, alongside domesticated poultry, play a central role in the transmission cycle of avian influenza viruses. Seasonal migration of these species can facilitate the spread of the virus across extensive geographic regions. Surveillance of wild bird populations is therefore critical for informing disease management strategies and conducting thorough risk assessments.

Challenges:
Effective control of avian influenza faces several challenges. Mass culling of infected birds, a common outbreak management strategy, can result in substantial financial losses for poultry farmers, often generating resistance from affected communities. Vaccine hesitancy and skepticism toward preventive interventions, frequently fueled by misinformation, further complicate disease control efforts.

Identifying the source of outbreaks is particularly difficult due to unregulated or illicit trade of live poultry, including in traditional wet markets. Additionally, the high costs associated with vaccine development-including research, regulatory approval, clinical trials, and testing-pose significant barriers to market growth in avian influenza prevention.

Regional Trends:
North America currently leads in the development and implementation of avian influenza prevention and control measures. The United States, in particular, hosts prominent manufacturers of vaccines and diagnostic tools, supported by extensive poultry industries in both the U.S. and Canada. Strict food safety regulations and robust biosecurity protocols drive the adoption of these measures across commercial operations.

The Asia-Pacific region, however, is emerging as the fastest-growing market for avian influenza management. Nations such as China, India, and Vietnam, with high rates of poultry production and consumption, face increased vulnerability to outbreaks, often linked to migratory bird populations. This elevated risk is accelerating the adoption of comprehensive surveillance, vaccination, and containment strategies throughout the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2347

Recent Developments:
• In July 2023, The vaccination campaign scheduled to commence in October 2023 in France chosen Boehringer Ingelheim, a German company, to supply the required quantity of 80 million doses of avian influenza vaccines. By commencing this campaign, France achieved the distinction of being the inaugural member state of the European Union to immunize poultry against avian influenza. Positive test results for vaccines manufactured in France by Ceva Animal Health and Boehringer Ingelheim were reported by officials of the Ministry of Agriculture last month.

Segmentation of Bird Flu Market -
By Virus Type:
• H5N1
• H7N9
• H5N6
• H5N8
• H10N8
• H9N2
• Others
By Test Type:
• PCR Tests
• ELISA Tests
• Hemagglutination Assays
• Virus Isolation Tests
• Next Generation Sequencing
• Others
By Treatment Type:
• Vaccines
• Antiviral Medication
• Immunomodulators
• Others
By Animal Type:
• Chickens
• Ducks
• Geese & Swans
• Pigeons
• Guinea Fowls
• Turkeys
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/bird-flu-market/2347

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.